Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Colorectal Carcinoma
96%
Neoplasm
58%
Tumor Growth
52%
Malignant Neoplasm
44%
Metastasis
35%
Distant Metastasis
33%
Drug Resistance
28%
Oxaliplatin
25%
Osteopontin
25%
Survivin
23%
microRNA
22%
Catenin
17%
Metastasis Potential
17%
Liver Metastasis
14%
Sorafenib
14%
Carcinogenesis
13%
Chir 265
12%
Arginase
12%
Chemotherapy
11%
Primary Tumor
9%
Arginine
8%
Preclinical Study
7%
Combination Therapy
7%
Recurrence Free Survival
6%
Everolimus
6%
Fascin
6%
Synapsin I
6%
Caveolin 1
6%
Antiapoptotic
6%
Non Insulin Dependent Diabetes Mellitus
6%
Sodium Glucose Cotransporter 2 Inhibitor
6%
Lung Metastasis
5%
Messenger RNA
5%
Dipeptidyl Peptidase IV Inhibitor
5%
Biochemistry, Genetics and Molecular Biology
Tumor Progression
52%
Drug Resistance
38%
Real-Time Polymerase Chain Reaction
27%
Cancer Staging
24%
Chemosensitivity
20%
Survivin
19%
Cell Invasion
17%
Cell Migration
17%
MicroRNA
16%
Catenin
16%
Cancer Stem Cell
15%
Fascin
12%
Caveolin 1
12%
SH3 Domain
12%
LIM Domain
12%
Peptidase
12%
Dipeptidyl Peptidase
12%
Interstitial Collagenase
12%
CD44
12%
CD29
12%
Leukocyte
12%
Multivariate Analysis
12%
Overall Survival
12%
Synapsin I
12%
Osteopontin
12%
Angiogenesis
12%
Cancer Cell
11%
down Regulation
10%
Gene Expression
8%
Cell Proliferation
8%
Focal Adhesion
8%
Mesenchymal-Epithelial Transition
8%
Adhesion Protein
8%
Mucosa
6%
Platelet Count
6%
Immunocompetent Cell
6%
Platelet
6%
Lymphocyte
6%
Protein Expression
5%
SCID Mouse
5%
Mouse Model
5%
Medicine and Dentistry
Hepatocellular Carcinoma
62%
Metastatic Carcinoma
57%
Colorectal Carcinoma
46%
Cancer Stem Cell
32%
Cell Migration
27%
Neoplasm
24%
Mesenchymal-Epithelial Transition
20%
Carcinoma Cell
18%
Metastasis Potential
17%
Distant Metastasis
16%
microRNA
16%
Tumor Progression
15%
Chemosensitivity
15%
Liver Metastasis
15%
Cell Invasion
15%
Survivin
13%
Carcinogenesis
12%
Sorafenib
12%
Primary Tumor
11%
In Vitro
9%
Cell Line
7%
Malignant Neoplasm
6%
Microarray Analysis
6%
Real-Time Polymerase Chain Reaction
6%
Recurrence Free Survival
6%
Translational Research
6%
Cytotechnology
6%
Sodium Glucose Cotransporter 2 Inhibitor
6%
Patient with Type 2 Diabetes
6%
Maturity Onset Diabetes of the Young
6%
Programmed Cell Death
5%
Cancer Cell
5%
Daughter Cell
5%
Dipeptidyl Peptidase-4 Inhibitor
5%